相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Management of Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease
Dennis Andress et al.
Endocrine Practice (2013)
Vitamin D receptor activation in a diabetic-like environment: Potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways
T. Zitman-Gal et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Comparative Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin-Receptor Blockade on Inflammation during Hemodialysis
Jorge L. Gamboa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure
B. Gonzalez-Diez et al.
MOLECULAR BIOLOGY REPORTS (2012)
Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats
Jane L. Finch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
Charalambos Antoniades et al.
CIRCULATION (2011)
Vitamin D Therapy and Cardiovascular Health
Suzanne E. Judd et al.
CURRENT HYPERTENSION REPORTS (2011)
Vitamin D Receptor Activator Reduces Oxidative Stress in Hemodialysis Patients With Secondary Hyperparathyroidism
Motoko Tanaka et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Calcitriol Treatment Attenuates Inflammation and Oxidative Stress in Hemodialysis Patients with Secondary Hyperparathyroidism
Chia-Chao Wu et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Differential Effects of Paricalcitol and Calcitriol on Intestinal Calcium Absorption in Hemodialysis Patients
Richard J. Lund et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Effects of Paricalcitol and Enalapril on Atherosclerotic Injury in Mouse Aortas
Kazim Husain et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Oral Administration of an Active Form of Vitamin D3 (Calcitriol) Decreases Atherosclerosis in Mice by Inducing Regulatory T Cells and Immature Dendritic Cells With Tolerogenic Functions
Masafumi Takeda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Vitamin D: modulator of the immune system
Femke Baeke et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-α and IL-8 production by human peripheral blood mononuclear cells
Theodoros Eleftheriadis et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2010)
Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study
Neal Mittman et al.
KIDNEY INTERNATIONAL (2010)
Combination Therapy with Paricalcitol and Enalapril Ameliorates Cardiac Oxidative Injury in Uremic Rats
Kazim Husain et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Vitamin D Deficiency and Risk for Cardiovascular Disease
Suzanne E. Judd et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2009)
Kynurenine, quinolinic acid-The new factors linked to carotid atherosclerosis in patients with end-stage renal disease
Krystyna Pawlak et al.
ATHEROSCLEROSIS (2009)
The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease
Krystyna Pawlak et al.
ATHEROSCLEROSIS (2009)
Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients
Aline T. Peres et al.
HEMODIALYSIS INTERNATIONAL (2009)
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms
Joerg C. Schefold et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Effect of a Hemodiafiltration Session with On-Line Regeneration of the Ultrafiltrate on Oxidative Stress
B. Gonzalez-Diez et al.
BLOOD PURIFICATION (2008)
Paricalcitol reduces albuminuria and inflammation in chronic kidney disease - A randomized double-blind pilot trial
Pooneh Alborzi et al.
HYPERTENSION (2008)
Vitamin D Receptor Activators Can Protect against Vascular Calcification
Suresh Mathew et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappa B signaling
Xiaoyue Tan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection
D. Grotto et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD
D Coyne et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?
A Levin et al.
KIDNEY INTERNATIONAL (2005)
Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease
BP Oberg et al.
KIDNEY INTERNATIONAL (2004)
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
F Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
SM Sprague et al.
KIDNEY INTERNATIONAL (2003)
Oxidative modification of proteins during aging
RL Levine et al.
EXPERIMENTAL GERONTOLOGY (2001)
Manifestations of oxidant stress in uremia
J Himmelfarb et al.
BLOOD PURIFICATION (2001)
Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients
G Clermont et al.
CARDIOVASCULAR RESEARCH (2000)
Hemodialysis impairs endothelial function via oxidative stress - Effects of vitamin E-coated dialyzer
H Miyazaki et al.
CIRCULATION (2000)
Oxidative modification of low-density lipoprotein (LDL) in HD patients: Role in electronegative LDL formation
O Ziouzenkova et al.
BLOOD PURIFICATION (2000)
Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance
M Morena et al.
BLOOD PURIFICATION (2000)
Evaluation of oxidant stress in dialysis patients
GJ Handelman
BLOOD PURIFICATION (2000)
分享论文
